Cerevel Therapeutics Holdings (CERE Investigation)

Levi & Korsinsky announces it has commenced an investigation (Cerevel Therapeutics Holdings CERE Investigation) of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) concerning possible breaches of fiduciary duty.